These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 1292798)
1. [Electroencephalographic study of trypanosomes in meningoencephalitic stage of human African trypanosomiasis from Trypanosoma brucei gambiense before and after treatment with DL-alphadifluoromethyl- ornithine hydrochloride monohydrate (DFMO)]. Hamon JF; Camara P Bull Soc Pathol Exot; 1992; 85(5):378-84. PubMed ID: 1292798 [TBL] [Abstract][Full Text] [Related]
2. [A trial treatment with eflornithine of trypanosomiasis caused by Trypanosoma brucei gambiense in the Peoples Republic of the Congo]. Eozenou P; Jannin J; Ngampo S; Carme B; Tell GP; Schechter PJ Med Trop (Mars); 1989; 49(2):149-54. PubMed ID: 2507863 [TBL] [Abstract][Full Text] [Related]
3. [Treatment of sleeping disease caused by trypanosoma brucei gambiense with alpha-difluoromethylornithine (DFMO) in a rural hospital in Zaire]. De Groof D; Bruneel H; Musumari TS; Ruppol JF Med Trop (Mars); 1992; 52(4):369-75. PubMed ID: 1494306 [TBL] [Abstract][Full Text] [Related]
4. [The use of difluoromethylornithine in congenital trypanosomiasis due to Trypanosoma brucei-gambiense]. Pepin J; Guern C; Milord F; Ethier L; Bokelo M; Schechter PJ Med Trop (Mars); 1989; 49(1):83-5. PubMed ID: 2498607 [TBL] [Abstract][Full Text] [Related]
5. Eflornithine is safer than melarsoprol for the treatment of second-stage Trypanosoma brucei gambiense human African trypanosomiasis. Chappuis F; Udayraj N; Stietenroth K; Meussen A; Bovier PA Clin Infect Dis; 2005 Sep; 41(5):748-51. PubMed ID: 16080099 [TBL] [Abstract][Full Text] [Related]
6. Nifurtimox-eflornithine combination therapy for second-stage Trypanosoma brucei gambiense sleeping sickness: a randomized clinical trial in Congo. Priotto G; Kasparian S; Ngouama D; Ghorashian S; Arnold U; Ghabri S; Karunakara U Clin Infect Dis; 2007 Dec; 45(11):1435-42. PubMed ID: 17990225 [TBL] [Abstract][Full Text] [Related]
7. [Treatment of human trypanosomiasis caused by Trypanosoma brucei gambiense using alpha-difluoromethylornithine. Results in 7 patients]. Taelman H; Marcelis L; Sonnet J; Kazyumba G; Van den Enden E; Wery M; Schechter PJ Bull Soc Pathol Exot Filiales; 1988; 81(3 Pt 2):578-88. PubMed ID: 3143491 [TBL] [Abstract][Full Text] [Related]
8. Further studies on difluoromethylornithine in African trypanosomes. McCann PP; Bacchi CJ; Clarkson AB; Seed JR; Nathan HC; Amole BO; Hutner SH; Sjoerdsma A Med Biol; 1981 Dec; 59(5-6):434-40. PubMed ID: 6175860 [TBL] [Abstract][Full Text] [Related]
9. Effectiveness of melarsoprol and eflornithine as first-line regimens for gambiense sleeping sickness in nine Médecins Sans Frontières programmes. Balasegaram M; Young H; Chappuis F; Priotto G; Raguenaud ME; Checchi F Trans R Soc Trop Med Hyg; 2009 Mar; 103(3):280-90. PubMed ID: 18947846 [TBL] [Abstract][Full Text] [Related]
10. Efficacy and toxicity of eflornithine for treatment of Trypanosoma brucei gambiense sleeping sickness. Milord F; Pépin J; Loko L; Ethier L; Mpia B Lancet; 1992 Sep; 340(8820):652-5. PubMed ID: 1355219 [TBL] [Abstract][Full Text] [Related]
11. [EEG and treatment with Arsobal in human African trypanosomiasis]. Giordano C; Boa FY; Kouassi B; Piquemal M; Akani F; Yapi P; Sonan T Bull Soc Pathol Exot Filiales; 1988; 81(3 Pt 2):482-3. PubMed ID: 3197245 [TBL] [Abstract][Full Text] [Related]
12. Treatment of human late stage gambiense trypanosomiasis with alpha-difluoromethylornithine (eflornithine): efficacy and tolerance in 14 cases in Côte d'Ivoire. Doua F; Boa FY; Schechter PJ; Miézan TW; Diai D; Sanon SR; De Raadt P; Haegele KD; Sjoerdsma A; Konian K Am J Trop Med Hyg; 1987 Nov; 37(3):525-33. PubMed ID: 3120607 [TBL] [Abstract][Full Text] [Related]
13. Eflornithine for the treatment of human African trypanosomiasis. Burri C; Brun R Parasitol Res; 2003 Jun; 90 Supp 1():S49-52. PubMed ID: 12811548 [TBL] [Abstract][Full Text] [Related]
16. In vivo evaluation of sixteen plant extracts on mice inoculated with Trypanosoma brucei gambiense. Youan BB; Coulibaly S; Miezan TB; Doua F; Bamba M Bull World Health Organ; 1997; 75(4):343-8. PubMed ID: 9342893 [TBL] [Abstract][Full Text] [Related]
17. Sleeping hearts: the role of the heart in sleeping sickness (human African trypanosomiasis). Blum JA; Burri C; Hatz C; Kazumba L; Mangoni P; Zellweger MJ Trop Med Int Health; 2007 Dec; 12(12):1422-32. PubMed ID: 18076548 [TBL] [Abstract][Full Text] [Related]
18. Equivalence trial of melarsoprol and nifurtimox monotherapy and combination therapy for the treatment of second-stage Trypanosoma brucei gambiense sleeping sickness. Bisser S; N'Siesi FX; Lejon V; Preux PM; Van Nieuwenhove S; Miaka Mia Bilenge C; Būscher P J Infect Dis; 2007 Feb; 195(3):322-9. PubMed ID: 17205469 [TBL] [Abstract][Full Text] [Related]
19. Mortality trends and risk factors in advanced stage-2 Human African Trypanosomiasis: A critical appraisal of 23 years of experience in the Democratic Republic of Congo. Kazumba LM; Kaka JT; Ngoyi DM; Tshala-Katumbay D PLoS Negl Trop Dis; 2018 Jun; 12(6):e0006504. PubMed ID: 29897919 [TBL] [Abstract][Full Text] [Related]
20. [Electroencephalographic study of meningoencephalitis from Trypanosoma gambiense before and after treatment with melarsoprol]. Hamon JF; Camara P Neurophysiol Clin; 1991 Aug; 21(3):173-81. PubMed ID: 1944068 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]